P165 Association between vitamin D deficiency and extended duration of COVID-19 symptoms

Autor: SA Roberts, ST Lugg, AA Faniyi, SE Faustini, C Faniyi, J Duffy, M Hewison, A Shields, AG Richter, D Parekh, A Scott, DR Thickett

Publikováno v: ‘Infinity War’ – Ongoing clinical challenges in COVID-19.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8d2148c0b9643577b880282c921589fa
https://doi.org/10.1136/thorax-2022-btsabstracts.299

Self-injectable adrenaline devices: is training necessary?

Autor: Lavanya Diwakar, Heslegrave J, Ag, Richter, Ap, Huissoon, Mt, Krishna

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b36fae1294fe3bd9d9927ff20a68ad38
https://pubmed.ncbi.nlm.nih.gov/20945620

Protocol for a feasibility and acceptability study for UK general population paediatric type 1 diabetes screening-the EarLy Surveillance for Autoimmune diabetes (ELSA) study.

Autor: Quinn LM; Institute of Immunology and Immunotherapy, College of Medicine and Health, University of Birmingham, Birmingham, UK., Dias RP; Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Department of Paediatric Endocrinology, Birmingham Women and Children's Hospital, Birmingham, UK., Greenfield SM; Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Richter AG; Clinical Immunology Service, University of Birmingham, Birmingham, UK., Garstang J; Birmingham Community Healthcare NHS Trust, Birmingham, UK.; School of Nursing, University of Birmingham, Birmingham, UK., Shukla D; Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Clinical Research Network, Lead for Primary Care (CRN West Midlands), National Institute for Health and Care Research, Royal Wolverhampton Hospital, Wolverhampton, UK., Acharjee A; Institute of Cancer and Genomic Medicine, University of Birmingham, Birmingham, UK.; MRC Health Data Research UK (HDR UK), Birmingham, UK.; Institute of Translational Medicine, University Hospitals Birmingham NHS, Birmingham, UK.; Centre for Health Data Research, University of Birmingham, Birmingham, UK., Gkoutos G; Institute of Cancer and Genomic Medicine, University of Birmingham, Birmingham, UK.; MRC Health Data Research UK (HDR UK), Birmingham, UK.; Institute of Translational Medicine, University Hospitals Birmingham NHS, Birmingham, UK.; Centre for Health Data Research, University of Birmingham, Birmingham, UK., Oram R; University of Exeter, Exeter, UK., Faustini S; Clinical Immunology Service, University of Birmingham, Birmingham, UK., Boiko O; Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Litchfield I; Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Boardman F; Warwick Applied Health, Warwick Medical School, Warwick, UK., Zakia F; Community Connexions, Birmingham Community Healthcare NHS Foundation Trust, Birmingham, UK., Burt C; Community Connexions, Birmingham Community Healthcare NHS Foundation Trust, Birmingham, UK., Connop C; INVOLVE co-applicant, Birmingham, UK., Lepley A; INVOLVE co-applicant, Birmingham, UK., Gardner C; INVOLVE co-applicant, Birmingham, UK., Dayan C; Division of Infection and Immunity, School of Medicine, University of Cardiff, Cardiff, UK., Barrett T; Institute of Cancer and Genomic Medicine, University of Birmingham, Birmingham, UK., Narendran P; Institute of Immunology and Immunotherapy, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Department of Diabetes, University Hospitals of Birmingham, Birmingham, UK.

Publikováno v: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2024 Dec 02, pp. e15490. Date of Electronic Publication: 2024 Dec 02.

Comparison of short- and long-term humoral immune responses to pneumococcal polysaccharide and glycoconjugate vaccines in an HIV-infected population.

Autor: Faustini SE; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, England, UK. Electronic address: S.E.Faustini@bham.ac.uk., Hodson J; Research Development and Innovation, Institute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, England, UK., Birtwistle J; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, England, UK., Whitelegg A; University Hospital Southampton NHS Foundation Trust, Southampton, England, UK., Masuka S; HIV Services, Queen Elizabeth Hospital Birmingham, Birmingham, England, UK., Singo M; HIV Services, Queen Elizabeth Hospital Birmingham, Birmingham, England, UK., Chigiga J; HIV Services, Queen Elizabeth Hospital Birmingham, Birmingham, England, UK., Shields A; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, England, UK., Plant T; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, England, UK., Drayson MT; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, England, UK., Manavi K; HIV Services, Queen Elizabeth Hospital Birmingham, Birmingham, England, UK., MacLennan CA; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, England, UK; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Richter AG; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, England, UK.

Publikováno v: The Journal of infection [J Infect] 2024 Nov; Vol. 89 (5), pp. 106282. Date of Electronic Publication: 2024 Sep 24.

Influence of individuals' determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination.

Autor: Chambers ES; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK. emma.chambers@qmul.ac.uk., Cai W; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK., Vivaldi G; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK., Jolliffe DA; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK., Perdek N; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK., Li W; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK., Faustini SE; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Gibbons JM; Centre for Genomics and Child Health, Blizard Institute, Barts and the London School of Medicine and Dentristry, Queen Mary University of London, London, E1 2AT, UK., Pade C; Centre for Genomics and Child Health, Blizard Institute, Barts and the London School of Medicine and Dentristry, Queen Mary University of London, London, E1 2AT, UK., Richter AG; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Coussens AK; Infectious Diseases and Immune Defence Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, 7925, South Africa., Martineau AR; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2024 May 22; Vol. 9 (1), pp. 87. Date of Electronic Publication: 2024 May 22.